ONLINE DATABASE SEARCH -
HIV-LS-372-MEMO
1.
60648 HIV-LS-372;
PUBMED-HIV-4/18/2007
Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of
l-chicoric acid, as new HIV-1 integrase inhibitors
Lee, SU, Shin, CG, Lee, CK, and Lee, YS
Eur J Med Chem
2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
2.
60649 HIV-LS-372;
PUBMED-HIV-4/18/2007
Mutations in Human
Immunodeficiency Virus Type-1 RNase H Primer Grip Enhance
3'-Azido-3'-Deoxythymidine Resistance
Delviks-Frankenberry, KA, Nikolenko, GN, Barr, R, and Pathak,
VK
J Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
3.
60650 HIV-LS-372;
PUBMED-HIV-4/18/2007
Cytidine deaminases APOBEC3G and APOBEC3F interact with HIV-1 integrase
and inhibit proviral DNA formation
Luo, K, Wang, T, Liu, B, Tian, C, Xiao, Z, Kappes, J, and Yu,
XF
J Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
4.
60651 HIV-LS-372;
PUBMED-HIV-4/18/2007
Dihydroxypyrimidine-4-carboxamides as Novel Potent and Selective HIV
Integrase Inhibitors
Pace, P, Francesco, ME, Gardelli, C, Harper, S, Muraglia, E, Nizi, E,
Orvieto, F, Petrocchi, A, Poma, M, Rowley, M, Scarpelli, R, Laufer, R, Paz, OG,
Monteagudo, E, Bonelli, F, Hazuda, D, Stillmock, KA, and Summa,
V
J Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
5.
60652 HIV-LS-372;
PUBMED-HIV-4/18/2007
Tetraphenylporphyrin-cobalt(III) Bis(1,2-dicarbollide) Conjugates: From
the Solution Characteristics to Inhibition of HIV Protease
Kubat, P, Lang, K, Cigler, P, Kozisek, M, Matejicek, P, Janda, P,
Zelinger, Z, Prochazka, K, and Kral, V
J Phys Chem B 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
6.
60653 HIV-LS-372;
PUBMED-HIV-4/18/2007
Synthesis and anti-HIV activity of trivalent CD4-mimetic
miniproteins
Li, H, Guan, Y, Szczepanska, A, Moreno-Vargas, AJ, Carmona, AT, Robina,
I, Lewis, GK, and Wang, LX
Bioorg Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
7.
60654 HIV-LS-372;
PUBMED-HIV-4/18/2007
Synergistic inhibition of HIV-1 infection by combinations of soluble
polyanions with other potential microbicides
Gantlett, KE, Weber, JN, and Sattentau, QJ
Antiviral Res 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
8.
60655 HIV-LS-372;
PUBMED-HIV-4/18/2007
Syntheses and anti-HIV activities of (+/-)-norcarbovir and
(+/-)-norabacavir
Huang, W, Miller, MJ, De, Clercq E, and Balzarini,
J
Org Biomol Chem 2007.
5(8): 1164-6
View Data on the NIAID Therapeutics Website
HYPERLINK:
9.
60656 HIV-LS-372;
PUBMED-HIV-4/18/2007
Anti-retroviral activity of GMP-grade stampidine against genotypically
and phenotypically nucleoside reverse transcriptase inhibitor resistant
recombinant human immunodeficiency virus. An in vitro study
Uckun, FM, DuMez, D, Qazi, S, Tibbles, H, and Venkatachalam,
TK
Arzneimittelforschung 2007.
57(2): 112-21
View Data on the NIAID Therapeutics Website
HYPERLINK:
10.
60657 HIV-LS-372;
PUBMED-HIV-4/18/2007
Two New Compounds and Anti-HIV Active Constituents from Illicium
verum
Song, WY, Ma, YB, Bai, X, Zhang, XM, Gu, Q, Zheng, YT, Zhou, J, and Chen,
JJ
Planta Med 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
11.
60658 HIV-LS-372;
PUBMED-HIV-4/18/2007
Synthesis and in vitro anti-HIV activities of didanosine
prodrugs
Sriram, D, Yogeeswari, P, Babu, NR, and Kurre, PN
J Enzyme Inhib Med Chem 2007. 22(1): 51-55
View Data on the NIAID Therapeutics Website
HYPERLINK:
12.
60659 HIV-LS-372;
WOS-HIV-4/8/2007
Langerin is a natural barrier to HIV-1 transmission by Langerhans
cells
de Witte, L, Nabatov, A, Pion, M, Fluitsma, D, de Jong, MAWP, de Gruijl,
T, Piguet, V, van Kooyk, Y, and Geijtenbeek, TBH
NATURE MEDICINE 2007.
13(3): 367-371, 5
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000244715700051
13.
60660 HIV-LS-372;
WOS-HIV-4/8/2007
Effect of the HIV protease inhibitor TMC114, coadministered with low-dose
ritonavir, on the pharmacokinetics of digoxin in healthy
volunteers
Sekar, VJ, El Malt, M, De Paepe, E, Mack, R, De Pauw, M, Vangeneugden, T,
Lefebvre, E, and Hoetelmans, R
CLINICAL PHARMACOLOGY & THERAPEUTICS 2007. 81: S82-S83, 2
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000244782900242
14.
60661 HIV-LS-372;
EMBASE-HIV-4/19/2007
GS-8374, a Novel Phosphonate HIV Protease Inhibitor with Potent In Vitro
Antiretroviral Activity, Low Metabolic Toxicity, and Favorable Resistance
Profile
Callebaut, Christian, Stray, Kirsten, Tsai, Luong, Xu, Lianhong, He,
Gong-Xin, Mulato, Andrew, Priskich, Tina, Parkin, Neil, Lee, William, and
Cihlar, Tomas
Antiviral Research 2007.
74(3): A27-90
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4N3X611-3/2/dddbdc2129b6abe92e78ff74b45fa58a
15.
60662 HIV-LS-372;
EMBASE-HIV-4/19/2007
Synthesis, Anti-HIV and CD4 Down-Modulation Activities of Novel CADA
Compounds
Anugu, Sreenivasa, Bell, Thomas, Duffy, Noah, Vermeire, Kurt, and Schols,
Dominique
Antiviral Research
2007. 74(3):
A48-A30
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4N3X611-1T/2/025446fa16a7fcc80531b6ea8d70e3ca
16.
60663 HIV-LS-372;
EMBASE-HIV-4/19/2007
Design, Synthesis, Anti-HIV and Cytotoxicity of Novel Heterocyclic
Compounds
Selvam, Periyasamy, Murugesh, Narayanan, Chandramohan, Markandavel, De
Clercq, Erik, and Pannecouque, Christophe
Antiviral Research 2007.
74(3): A51-A30
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4N3X611-22/2/e436907421d76e8c98c88b1f0b2e7be7
17.
60664 HIV-LS-372;
EMBASE-HIV-4/19/2007
Design, Synthesis and Anti-HIV Activity of Some Novel Isatin
Derivatives
Selvam, Periyasamy, Murugesh, Narayanan, Chandramohan, Markandavel,
Debyser, Zeger, Witvrouw, Myriam, and Engelborghs, Yves
Antiviral Research 2007.
74(3): A68-A67
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4N3X611-3J/2/3f46bbe8b7e0bc8019c4a8e4791d33d8
18.
60665 HIV-LS-372;
EMBASE-HIV-4/19/2007
Targeting the Sticky Fingers
of HIV-1
Blumenthal, Robert and Dimitrov, Dimiter S
Cell 2007. 129(2):
243-245
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WSN-4NHMXD1-8/2/3791ccd3cac222b79120792bf7c7138a
19.
60666 HIV-LS-372;
EMBASE-HIV-4/19/2007
Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting
the gp41 Fusion Peptide
Munch, Jan, Standker, Ludger, Adermann, Knut, Schulz, Axel, Schindler,
Michael, Chinnadurai, Raghavan, Pohlmann, Stefan, Chaipan, Chawaree, Biet,
Thorsten, Peters, Thomas, Meyer, Bernd, Wilhelm, Dennis, Lu, Hong, Jing, Weiguo,
Jiang, Shibo, Forssmann, Wolf-Georg, and Kirchhoff, Frank
Cell 2007. 129(2):
263-275
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WSN-4NHMXD1-D/2/9f96eb66ad3ba7437b9a667c481e9006
20.
60667 HIV-LS-372;
EMBASE-HIV-4/19/2007
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir
(MK-0518) in treatment-experienced patients with multidrug-resistant virus: a
phase II randomised controlled trial
Grinsztejn, Beatriz, Nguyen, Bach-Yen, Katlama, Christine, Gatell, Jose
M, Lazzarin, Adriano, Vittecoq, Daniel, Gonzalez, Charles J, Chen, Joshua,
Harvey, Charlotte M, and Isaacs, Robin D
The Lancet 2007.
369(9569): 1261-1269
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T1B-4NGCX8Y-12/2/aada5f0e19035eba9ebae4992a624a9d
21.
60668 HIV-LS-372;
WOS-HIV-4/15/2007
Regioselective synthesis and anti-HIV activity of the novel 2-and
4-substituted pyrazolo[4,5-e][1,2,4]thiadiazines
Liu, XY, Yan, RZ, Chen, NG, and Xu, WF
CHINESE CHEMICAL LETTERS 2007. 18(2): 137-140, 4
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000244770600006
22.
60669 HIV-LS-372;
EMBASE-HIV-4/19/2007
Entry inhibitor-based microbicides are active in vitro against HIV-1
isolates from multiple genetic subtypes
Ketas, Thomas J, Schader, Susan M, Zurita, Juan, Teo, Esther, Polonis,
Victoria, Lu, Min, Klasse, Per Johan, and Moore, John P
Virology 2007. In
Press, Corrected Proof: 256
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WXR-4NFXG6Y-2/2/ed3efb80176545e7ecccbfbcf312615e
23.
60670 HIV-LS-372;
EMBASE-HIV-4/19/2007
In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as
a microbicide candidate
Tao, Jian, Hu, Qinxue, Yang, Jing, Li, Rurun, Li, Xiuyi, Lu, Chengping,
Chen, Chaoyin, Wang, Ling, Shattock, Robin, and Ben,
Kunlong
Antiviral Research 2007.
In Press, Uncorrected Proof: 304
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4NFS18K-1/2/bf9c5c337af293bfc819359fc67d1d28
24.
60671 HIV-LS-372;
EMBASE-HIV-4/19/2007
Synthesis and evaluation of 2'-substituted cyclobutyl nucleosides and
nucleotides as potential anti-HIV agents
Li, Yongfeng, Mao, Shuli, Hager, Michael W, Becnel, Kimberlynne D,
Schinazi, Raymond F, and Liotta, Dennis C
Bioorganic & Medicinal Chemistry Letters 2007. In Press, Corrected Proof: 304
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4NDDM03-3/2/c4fefd14b8e816a47d7c378ca0a7c070